靶向Hippo通路的基因治疗促进猪心肌梗死后心肌细胞再生
研究在猪缺血再灌注心肌梗死模型中,于梗死后2周经导管心内膜下注射AAV9-Sav-shRNA或对照AAV9-GFP至边界区心肌细胞。注射3个月后,高剂量AAV9-Sav-shRNA组射血分数改善14.3%,出现心肌细胞分裂证据、瘢痕缩小、毛细血管密度增加及心肌细胞倍性降低,且耐受良好、未诱导死亡,肝肺病理未见肿瘤形成。
要点
- 梗死后2周经导管心内膜下局部递送AAV9-Sav-shRNA可敲低Hippo通路基因Sav。
- 高剂量组射血分数改善14.3%,并见心肌细胞分裂、瘢痕缩小与毛细血管密度增加。
- 治疗耐受良好、未诱导死亡,肝肺病理未见肿瘤形成。
核心结论
- 局部递送AAV9-Sav-shRNA至猪心梗后边界区心肌细胞可实现组织再生并改善心功能,可能用于治疗心力衰竭。
研究设计与样本
- 在猪缺血再灌注诱导心肌梗死模型中,梗死后2周经导管心内膜下注射AAV9-Sav-shRNA或携带GFP的对照AAV9载体至边界区心肌细胞。
主要发现
- 注射3个月后,高剂量AAV9-Sav-shRNA组射血分数改善14.3%,并见心肌细胞分裂证据和瘢痕缩小。
- AAV9-Sav-shRNA处理心脏毛细血管密度增加、心肌细胞倍性降低。
- 治疗耐受良好、未诱导死亡,肝肺病理未见肿瘤形成。
临床怎么用
- 提示在梗死后左心室收缩功能障碍阶段,靶向边界区心肌细胞敲低Hippo通路的局部基因治疗可能改善心功能并促进组织再生。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Human heart failure, a leading cause of death worldwide, is a prominent example of a chronic disease that may result from poor cell renewal. The Hippo signaling pathway is an inhibitory kinase cascade that represses adult heart muscle cell (cardiomyocyte) proliferation and renewal after myocardial infarction in genetically modified mice. Here, we investigated an adeno-associated virus 9 (AAV9)-based gene therapy to locally knock down the Hippo pathway gene Salvador (Sav) in border zone cardiomyocytes in a pig model of ischemia/reperfusion-induced myocardial infarction. Two weeks after myocardial infarction, when pigs had left ventricular systolic dysfunction, we administered AAV9-Sav-short hairpin RNA (shRNA) or a control AAV9 viral vector carrying green fluorescent protein (GFP) directly into border zone cardiomyocytes via catheter-mediated subendocardial injection. Three months after injection, pig hearts treated with a high dose of AAV9-Sav-shRNA exhibited a 14.3% improvement in ejection fraction (a measure of left ventricular systolic function), evidence of cardiomyocyte division, and reduced scar sizes compared to pigs receiving AAV9-GFP. AAV9-Sav-shRNA-treated pig hearts also displayed increased capillary density and reduced cardiomyocyte ploidy. AAV9-Sav-shRNA gene therapy was well tolerated and did not induce mortality. In addition, liver and lung pathology revealed no tumor formation. Local delivery of AAV9-Sav-shRNA gene therapy to border zone cardiomyocytes in pig hearts after myocardial infarction resulted in tissue renewal and improved function and may have utility in treating heart failure.
引用
- Liu S, Li K, Wagner Florencio L, et al. Gene therapy knockdown of Hippo signaling induces cardiomyocyte renewal in pigs after myocardial infarction. Sci Transl Med. 2021. PMID: 34193613. doi:10.1126/scitranslmed.abd6892
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。